DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Study of Topical Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) and a Phase III Comparative Treatment Study of HAL PDT in Female Genital Erosive Lichen Planus (GELP)

Information source: Oslo University Hospital
Information obtained from ClinicalTrials.gov on December 08, 2011
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Genital Erosive Lichen Planus

Intervention: clobetasolpropionate (Drug); hexaminolevulinate (Drug)

Phase: Phase 2/Phase 3

Status: Not yet recruiting

Sponsored by: Oslo University Hospital

Overall contact:
anne lise helgesen, cand med, Phone: 0047 98634403, Email: anneliseord@yahoo.no

Summary

To compare the effect and side effects of photodynamic treatment and traditional topical steroid treatment in female genital erosive lichen planus

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Primary outcome: Percentage change of GELP score and/or VAS score 6 weeks after start of treatment.

Secondary outcome: Percentage change of GELP score and/or VAS score 6 months after start of treatment.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Female.

Criteria:

Inclusion Criteria:

Women with symptomatically genital ELP, clinically verified by at least one doctor attended to the Vulva clinic.

Untreated for ELP for at least 4 weeks. Written Informed Consent signed Age 18 or above

Exclusion Criteria:

Current pelvic inflammatory disease, genital malignancy, or gynecological infection.

Known or suspected porphyria

Known allergy to hexaminolevulinate or similar compounds (e. g. hexaminolevulinate or aminolevulinic acid) Pregnancy and lactation Participation in other clinical study either concurrently or within the last 30 days

Locations and Contacts

anne lise helgesen, cand med, Phone: 0047 98634403, Email: anneliseord@yahoo.no

Rikshospitalet, OsloUniversity hospital, Oslo 0027, Norway
Additional Information

Starting date: August 2011
Last updated: January 24, 2011

Page last updated: December 08, 2011

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012